Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma

被引：21

作者：

Auner, Holger W. ^{[1
,2
]}

Garderet, Laurent ^{[2
,3
]}

Kroeger, Nicolaus ^{[2
,4
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, London, England

[2] Chron Malignancies Working Party European Soc Blo, Hamburg, Germany

[3] Hop St Antoine, F-75571 Paris, France

[4] Univ Med Ctr, Hamburg, Germany

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2015年 / 171卷 / 04期

关键词：

Autologous haematopoietic cell transplantation; multiple myeloma; elderly patients; comorbidities; BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; BLOOD STEM-CELLS; GREATER-THAN-OR-EQUAL-TO-70; YEARS; COMORBIDITY INDEX; YOUNGER PATIENTS; SURVIVAL; MELPHALAN; AGE; IMPROVEMENT;

D O I：

10.1111/bjh.13608

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

High-dose chemotherapy with melphalan followed by autologous haematopoietic cell transplantation (AHCT) is a standard of care in young patients (<65years) with multiple myeloma. Most myeloma patients, however, are older than 65years at the time of diagnosis, and the findings of numerous single-centre and registry studies provide evidence that AHCT can be a feasible and effective treatment option in these patients. Nevertheless, AHCT is not generally recommended as standard treatment in the elderly, due to the fact that a benefit of AHCT over conventional-dose therapy has not been demonstrated by prospective randomized trials. Yet, the use of AHCT has increased substantially in older patients in recent years, and an increasing number of reports suggest comparable outcomes for older and younger patients after AHCT. In this review we summarize the results of AHCT for elderly patients with multiple myeloma.

引用

页码：453 / 462

页数：10

共 50 条

[21] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents [J].

Merz, M. ;

Neben, K. ;

Raab, M. S. ;

Sauer, S. ;

Egerer, G. ;

Hundemer, M. ;

Hose, D. ;

Kunz, C. ;

Heiss, C. ;

Ho, A. D. ;

Goldschmidt, H. ;

Hillengass, J. .

ANNALS OF ONCOLOGY, 2014, 25 (01) :189-195

[22] In-Hospital Mortality and Post-Transplantation Complications in Elderly Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Population-Based Study [J].

Sanchez, Larysa ;

Sylvester, Michael ;

Parrondo, Ricardo ;

Mariotti, Veronica ;

Eloy, Jean Anderson ;

Chang, Victor T. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) :1203-1207

[23] Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma [J].

Harousseau, Jean-Luc ;

Moreau, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (25) :2645-2654

[24] Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects [J].

Jansen, Lina ;

Merz, Maximilian ;

Engelhardt, Monika ;

Weisel, Katja ;

Scheid, Christof ;

Straka, Christian ;

Langer, Christian ;

Salwender, Hans ;

Einsele, Hermann ;

Kroege, Nikolaus ;

Beelen, Dietrich W. ;

Dreger, Peter ;

Goldschmidt, Hartmut ;

Brenner, Hermann .

LEUKEMIA & LYMPHOMA, 2020, 61 (10) :2365-2374

[25] EARLY AND LATE RELAPSES OF MULTIPLE MYELOMA AFTER AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION [J].

Mamaeva, E. A. ;

Mendeleeva, L. P. ;

Solovyev, M., V ;

Firsova, M., V ;

Kraizman, A. A. ;

Arutyunyan, N. K. ;

Abakumova, A., V ;

Startsev, A. A. ;

Makunina, E. A. ;

Kondratieva, Y. A. ;

Kuzmina, L. A. .

GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (04) :512-525

[26] The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation [J].

Witte, Hanno M. ;

Bonorden, Bastian ;

Riecke, Armin ;

Biersack, Harald ;

Steinestel, Konrad ;

Merz, Hartmut ;

Feller, Alfred C. ;

Bernard, Veronica ;

Fetscher, Sebastian ;

von Bubnoff, Nikolas ;

Gebauer, Niklas .

CANCERS, 2020, 12 (04)

[27] Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failure [J].

Firsova, M., V ;

Mendeleeva, L. P. ;

Solovev, M., V ;

Rekhtina, I. G. ;

Pokrovskaya, O. S. ;

Urnova, E. S. ;

Soboleva, N. P. ;

Dvirnyk, V. N. ;

Klyasova, G. A. ;

Kuzmina, L. A. ;

Savchenko, V. G. .

TERAPEVTICHESKII ARKHIV, 2020, 92 (07) :70-76

[28] Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years [J].

Badros, A ;

Barlogie, B ;

Siegel, E ;

Morris, C ;

Desikan, R ;

Zangari, M ;

Fassas, A ;

Anaissie, E ;

Munshi, N ;

Tricot, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) :600-607

[29] Multiple myeloma and autologous haematopoietic stem-cell transplantation without cryopreservation: experiences of the Clinical Hematology Department of Casablanca, Morocco [J].

Fares, Salma ;

Hadri, Halima ;

Rachid, Mohamed ;

Moutiqui, Tarik ;

Oukkache, Bouchra ;

Quessar, Asmaa .

PAN AFRICAN MEDICAL JOURNAL, 2021, 39

[30] Comparison of autologous hematopoietic cell transplantation performed in tandem and in disease relapse in multiple myeloma patients [J].

Jungova, A. ;

Vokurka, S. ;

Schutzova, M. ;

Steinerova, K. ;

Mohammadova, L. ;

Karas, M. ;

Lysak, D. ;

Jindra, P. .

NEOPLASMA, 2018, 65 (06) :952-957

← 1 2 3 4 5 →